X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (142) 142
Book / eBook (13) 13
Publication (13) 13
Book Chapter (4) 4
Book Review (3) 3
Newspaper Article (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (101) 101
index medicus (72) 72
male (52) 52
cardiac & cardiovascular systems (49) 49
female (38) 38
animals (32) 32
adult (30) 30
middle aged (28) 28
catheter ablation (23) 23
cardiology (19) 19
immunology (19) 19
accessory pathways (18) 18
care and treatment (18) 18
surgery (18) 18
analysis (16) 16
catheter ablation - methods (16) 16
aged (15) 15
diagnosis (15) 15
treatment outcome (15) 15
ablation (14) 14
respiratory system (14) 14
tachycardia (14) 14
accessory cells (13) 13
adolescent (13) 13
electrocardiography (13) 13
medicine & public health (13) 13
research (13) 13
anatomy (12) 12
atrial-fibrillation (12) 12
children (12) 12
pediatrics (12) 12
physiology (12) 12
radiofrequency ablation (11) 11
cell biology (10) 10
dendritic cells (10) 10
health aspects (10) 10
medicine (10) 10
pathology (10) 10
physiological aspects (10) 10
radiofrequency catheter ablation (10) 10
t-cells (10) 10
atrial fibrillation - surgery (9) 9
catheters (9) 9
child (9) 9
heart (9) 9
heart conduction system - surgery (9) 9
inflammation (9) 9
mice (9) 9
patients (9) 9
abridged index medicus (8) 8
accessory pathway (8) 8
activation (8) 8
arrhythmia (8) 8
immune response (8) 8
medical equipment (8) 8
parkinson-white-syndrome (8) 8
receptor accessory protein (8) 8
supraventricular tachycardia (8) 8
accessory cell-function (7) 7
atrial fibrillation (7) 7
blood (7) 7
cancer (7) 7
case report (7) 7
catheter ablation - adverse effects (7) 7
child, preschool (7) 7
congenital heart disease (7) 7
cytokines (7) 7
diagnosis, differential (7) 7
disease (7) 7
infant (7) 7
interleukins (7) 7
methods (7) 7
oncology (7) 7
pathogenesis (7) 7
physiological apparatus (7) 7
research article (7) 7
review (7) 7
safety (7) 7
accessory atrioventricular connections (6) 6
anesthesiology (6) 6
arrhythmias, cardiac - surgery (6) 6
article (6) 6
biology (6) 6
cardiac arrhythmia (6) 6
cells, cultured (6) 6
complications (6) 6
cryoablation (6) 6
disease models, animal (6) 6
diseases (6) 6
engineering, biomedical (6) 6
follow-up studies (6) 6
hematology (6) 6
immune system (6) 6
in-vivo (6) 6
laboratories (6) 6
microbiology (6) 6
mortality (6) 6
nodal reentrant tachycardia (6) 6
parkinson-white syndrome (6) 6
peripheral vascular disease (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Physiology - Lung Cellular and Molecular Physiology, ISSN 1040-0605, 2015, Volume 308, Issue 7, pp. L619 - L627
Journal Article
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, ISSN 0022-5223, 11/2015, Volume 150, Issue 5, pp. 1222 - U757
Objectives: To determine the association between surgical management of pulmonary blood flow (PBF) at initial and staged procedures with survival to... 
MORTALITY | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | accessory pulmonary blood flow | systemic to pulmonary artery shunt | PULMONARY BLOOD-FLOW | tricuspid atresia | GLENN | CHILDREN | BLALOCK-TAUSSIG SHUNT | ATRESIA | RESPIRATORY SYSTEM | congenital heart disease | BIDIRECTIONAL CAVOPULMONARY ANASTOMOSIS
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2002, Volume 118, Issue 4, pp. 1205 - 1208
Glanzmann's thrombasthenia | transcription factor | X‐SCID | B‐CLL | Ras | SCT | skin involvement | product usage | modified international prognostic index (MIPI) | t(14;18) | peripheral stem cell transplantation | recombinant factor VIIa | coagulation | dose‐reduced conditioning | PAI‐1 | twins | megakaryoblastic leukaemia | total body irradiation | doxorubicin | prevention | vincristine | X‐chromosome inactivation | nasal‐type lymphoma | anaplastic lymphoma kinase | haematogones | ERK‐1 | intensive chemotherapy | TCR‐Vβ | marrow | lymphoproliferative disorder | selection | assay discrepancy | drug resistance | adult | non‐depleting anti‐CD4 antibody | clonal disease | treatment | CliniMACS® (v2·1) | fibrinogen | Bcl‐XL | etilefrine | interdomain acidic region a1 | proliferative activity | HIV‐1 | ELA2 mutation | cell‐free haemoglobin solution | Shwachman–Diamond syndrome | thromboxane A2 | myeloma | haemostasis | e19a2 | taxol | Bcl‐2 | rituximab | sex ratio | molecular genetics | mediated haematological disorders | myelofibrotic transformation | strain gauge plethysmography | lymphomas | Glivec® (Gleevec) | fulminant hepatitis | blood | CD34+ product functional capacity | toll‐like receptor | μ‐bcr breakpoint | lymphocyte | idiopathic myelofibrosis | unrelated | all‐trans retinoic acid | LDGL | European treatment results | screening | T‐cell add‐back | CTCL | adhesion molecule | mRNA analysis | immunosuppression | d‐dimer | smouldering myeloma | APC resistance | MyD88 | aplastic anaemia | evidence‐based medicine | allogeneic bone marrow transplantation | imatinib mesylate (STI 571) | thalidomide | cutaneous lymphocyte antigen | immune accessory molecules | immunoglobulin kappa light chain (Igκ) rearrangement | DEVDase activity | FVIIIa inactivation | farnesyltransferase inhibitors | intracellular cytokines | autoimmune | lymphoproliferative disease | cytogenetic abnormality | graft‐versus‐host disease | autografting | blast crisis | minor BCR/ABL | volume | DNA microarray | secretion | extranodal marginal zone B‐cell lymphoma (MZL) | guideline | SIL | transplantation | monocytic leukaemia | activation | MMP‐9 | haploidentical stem cell transplantation | low‐grade B‐cell lymphoma | PCR | hyperviscosity | γδ T cells | multidrug resistance | Factor V Leiden | l‐ferritin | follicular lymphoma (FL) | polyclonal gammopathy | VWF:RCo | lupus anticoagulant | platelet activation | duration | CBFB‐MYH11 | XIIIA gene | whole blood autologous stem cell transplantation | pericentric inversion of chromosome 9 | human | effectiveness | rituxan | TNFR | haemochromatosis | stem cell factor | translocation | responsive element | pesticide | marrow CD34+ cells | lymphoma | microvessel density | leukaemias | acute leukaemia | indolent myeloma | p38 MAP kinase | myelogeneous leukaemia | WT1 | thrombomodulin | core biopsy | platelet | Jurkat | rearrangement | reconstitution | CLL | NK cell development | bleeding | EPO | Jehovah's Witness | chelation therapy | assays | mitochondrial dysfunction | P‐glycoprotein | chemotherapy | non‐frozen haematopoietic stem cells | dendritic cells | biosynthesis | normal ranges | haemopoiesis | hereditary hyperferritinaemia–cataract syndrome | AC133+ cells | stem cells | TAL‐1 | CML | infants | angiogenesis | anti‐Pr autoimmune haemolysis | haematological recovery | classification | CMV | MLL gene rearrangement | deferiprone | haemolytic anaemia | mutation | randomized trials | thresholds | IL‐1α | osteosclerotic myeloma | leukaemia | Hodgkin's disease | CD154 | 1,25(OH)2D3 | myeloid leukaemia | regulatory proteins | isohaemagglutin | Waldenström's macroglobulinaemia | respiratory viruses | post‐transplant G‐CSF | over‐warfarinization | CTLA‐4 | erythroblast | STI‐571 | and adults | novel mutation | von Willebrand factor | transplant | Bcl‐2/IgH | foscarnet | cyclosporine | phospholipase C | statistical methodology | cardiovascular disease | strontium | BMT | triglycerides | Sézary syndrome | systematic review | unusually large VWF multimers | 7‐aminoactinomycin D | breakpoint | protein C gene mutations | marrow aspirate | X‐linked thrombocytopenia | reversal | extramedullary haematopoiesis | β‐globin | sickle cell | hypercoagulable state | endocrine late effects | historical controls | rhodamine | depletion | ALL | granulocyte colony‐stimulating factor receptor (G‐CSFR) | transfusion | polymorphism | non‐Hodgkin's lymphoma | heparin‐platelet factor 4 antibodies | iron metabolism | paediatrics | mutations | promyelocytic leukaemia | metaphase cytogenetics | autologous PBSC infusion | B‐cell antigen receptor | Golgi complex | erythropoiesis | thrombotic microangiopathy | cytotoxic T cells | MGUS | MDS | paraoxonase | tolerance | acquired activated protein C resistance | AML | multiple myeloma | concentrates | signal transduction | EVI‐1 gene | therapy‐related | idarubicin | diagnosis | high‐dose Ara‐C | VWF‐cleaving protease | warfarin | Hodgkin cells | MEL | glycoprotein | ATRA | cerebrovascular disorders | paroxysmal nocturnal haemoglobinuria | reduced intensity conditioning | antiplatelet antibody | PKC‐ζ | differentiation | persistent aplasia | anticoagulation | apoptosis | chronic ITP | receptor assembly | missense mutation | GATA‐1 | systemic lupus erythematosus | genetics | NHL | Evans’ syndrome | exon skipping | CD117 | real‐time polymerase chain reaction (PCR) | Epstein–Barr virus | PfEMP1 | erythropoietin | haematocrit | Burkitt's leukaemia | rates | myeloid/NK cell precursor acute leukaemia | SSH | interferon | risk factor | intravenous immune globulin | sterol isomerase (hSI) | trephine biopsy | hypersplenism | remission | thymic stromal cells | biopsy | e191a | VWF:CB | DVT | myelomonocytic leukaemia | inherited bone marrow failure syndrome | gelatin zymography | HOX11 | cure | PNH | cytogenetics | peripheral blood stem cell transplantation | MTT assay | oncology | myeloid tumours | homeodomain oncoprotein | low‐dose combination chemotherapy | randomization | protein | cholesterol | lymphoproliferation | cord blood transplantation | xenobiotic gene | BCRP | antioxidant | homing receptor | prognostic factor | relapse | 11q deletion | monitoring | childhood acute myelogenous leukaemia (AML) | plasma levels | stromal cells | neutrophil elastase | U937 cells | Grave's disease | hypodiploidy | veno‐occlusive disease | CD105 | somatic mosaicism | pyruvate kinase deficiency | gene expression | isoform | essential thrombocythaemia | CD20 | autoantibody | membrane phospholipid stability | post‐haemorrhagic anaemia | procalcitonin | matched unrelated donor | lymphoid malignancies | tumour cells | haemopoietic progenitors | prothrombin 20210A | mantle cell lymphoma | amifostine | febrile | cell line | phenotype | genetic | haemorrhagic episodes | expression | relative erythrocytosis | cataract | pneumatosis intestinalis | TGF‐β1 | trisomy 21 | collagen | GvHD | B cells | chromatin | antisickling agent | prognosis | type 2M von Willebrand disease | haematopoiesis | Nix‐0699 | priapism | CD79b | erythrocytosis | 3q21q26 aberration | necrosis | FISH | monocyte | myelodysplastic syndrome | venous thrombosis | Kilt syndrome | retinoids | CD40L | interleukin 1β | toxicity | CD40 | tissue factor | pulmonary hypertension | NOD/SCID mouse | caeruloplasmin | cytomegalovirus disease | 13q | EBV lymphoma | secondary autoimmune thrombocytopenic purpura | Reed–Sternberg cells | moderate pretest probability | variant | CD38 | CD34 | chimaerism | IVC thrombosis | self‐renewal | IL‐2 | haem biosynthesis | AIDS | band 3 protein | lymphocytic leukaemia | neutropenia | cytokine receptors | annexin V | IL‐8 | modification | IL‐6 | haemophilia A and B | radiotherapy | patient selection | chlorambucil | heparin‐induced thrombocytopenia | HAART | POEMS | MMSET | anaemia with excess of blasts (RAEB) | adults | common gamma chain | methotrexate | IgM | epidemiology | thrombosis | lymphoproliferative syndrome | transplantation (BMT) | cation permeability | sideroblastic anaemia | IFN‐gamma | mesenchymal stem cell | registry | integrin αIIbβ3 | disease | Isolex® 300i (v2·5) | thrombocytopenic purpura | P50 | parvovirus B19 | ineffective haematopoiesis | G‐CSF | PKLR gene splicing mutations | deep vein thrombosis | cells | T‐ALL | FAS | CD69 | Hb solubility | elderly patients | PCR (RQ‐PCR) | prophylactic platelet transfusion | anaemia with ringed sideroblasts (RARS) | unfractionated heparin | p53 | paediatric | androgen receptor gene | haemoglobin | hyperthyroidism | children | deletion | organ transplantation | review | safety | cytokines | flow cytometry | splenectomy | cDNA array | monocytes | CD95 | myelofibrosis | quantification | diffuse large B‐cell lymphoma (DLCL) | late complications | penetrance | haematopoietic progenitors | rheumatoid arthritis | primate model | protein C deficiency | eradication | osteocalcin | warfarin‐induced bleed | VIII | WHO classification | MRD | low‐molecular‐weight heparin | PBPC | infection | gender | signature | follow‐up | PCRA | lymphoblastic leukaemia | maintenance therapy | C282Y homozygosity | T cells | leucodepletion | fluid intake | immune tolerance | DNA‐topoisomerase II inhibitor | herpesviruses | Hu1D10 | VDJ | bone disease | cell cycle | TNF‐α | diathesis | cell isolation | accelerated/blastic phase | cellular differentiation | consolidation | transformation | vitamin K | Philadelphia chromosome | antiviral treatment | natural killer cells | HIV | venous thromboembolism | FGFR3 | incidence | endotoxin | engraftment | anticardiolipin antibodies | sarcoma | silent mutation | central retinal vein occlusion | health care savings | transfection | CNS leukaemia | refractory anaemia (RA) | major | adenovirus | RQ‐PCR | primary intestinal lymphoma (PIL) | obesity | group | von Willebrand's disease | doppler ultrasound | haemopoietic stem cells | immature phenotype | receptors | diabetes insipidus | 3′UTR | stem cell transplantation | survival | c‐kit | pamidronate | transfer | venous catheter | complete remission | T helper cells | neuropathy | ‘B’ symptoms | erythroid cells | with myeloid metaplasia | hyperlipidaemia | malignant lymphoma | erythrocyte recovery | β2‐microglobulin | glycophorin A | pathology | thalassaemia | death | mobilization | thrombocytopenia | C/S ratio | infarction | Wiskott–Aldrich syndrome | congenital neutropenia | recovery | malaria | donor | Helicobacter pylori | HL‐60 | immunotherapy | pathophysiology | phosphatidylinol 3‐kinases | immunohistochemistry | ADCC | monoblastic leukaemia | cytotoxicity | sheep | p16 methylation | paraprotein | graft rejection | inversion of chromosome 16 | anti‐prothrombin antibodies | therapy | mitochondria | VEGF | chromosome | spontaneous regression | factors | inv | repertoire β chain subfamily (TCR‐VB) | carrier | retinoic acid syndrome | CD7 | VII | growth | XIII deficiency | Marcks | cryptic splice site | CD34+ cells
Journal Article
Journal Article
Cardiovascular Journal of Africa, ISSN 1995-1892, 03/2018, Volume 29, Issue 2, pp. e5 - e7
We present a case of a six-year-old boy with complex partial anomalous pulmonary venous connections with accessory pulmonary veins, where multi-detector... 
Partial anomalous pulmonary venous connections | Accessory pulmonary veins | accessory pulmonary veins | CARDIAC & CARDIOVASCULAR SYSTEMS | partial anomalous pulmonary venous connections | Medical imaging | Sensors | Pulmonary arteries | Catheters | Veins & arteries | Case Report
Journal Article
Journal Article
Lung India, ISSN 0970-2113, 1/2019, Volume 36, Issue 1, pp. 38 - 47
Journal Article